Laparoscopic liver resection: 5-year experience at a single center by Tran Cong Duy Long et al.
Laparoscopic liver resection: 5-year experience at a single center
Tran Cong Duy Long • Nguyen Hoang Bac •
Nguyen Duc Thuan • Le Tien Dat • Dang Quoc Viet •
Le Chau Hoang Quoc Chuong
Received: 21 July 2013 / Accepted: 29 September 2013 / Published online: 7 November 2013
 The Author(s) 2013. This article is published with open access at Springerlink.com
Abstract
Background Hepatocellular carcinoma (HCC) is a com-
mon cancer, especially in the Association of Southeast
Asian Nations (ASEAN) region, where the prevalence of
hepatitis virus infection is high. Liver resection is a
potentially curative and popular therapy for HCC. Lapa-
roscopic surgery using minimally invasive techniques
potentially brings benefits to patients who need liver
resection for HCC. This study aimed to evaluate the
effectiveness, safety, and benefits of laparoscopic liver
resection for HCC with long-term follow-up evaluation.
Methods This cohort study with 5-year results of total
laparoscopic hepatectomy for HCC was conducted in one
center. Patients with HCC were selected for laparoscopic
liver resection by the same team. The operation also was
performed by one team of surgeons. The follow-up proto-
col was similar to that for open surgery. The patients were
scheduled to return for examination every 2 months after
the operation. The data for the patients were collected and
analyzed using SPSS software.
Results From January 2008 to December 2012, 173 enrolled
patients with HCC underwent laparoscopic liver resection. The
male-to-female ratio was 3:1. The mean age of the patients was
56 years (range 16–83 years). The follow-up period for 130
patients was 21.6 ± 16.0 months (range 0–60 months). The
mean tumor size was 3.73 cm (range 2–10 cm). The stages of
HCC according to the Barcelona Clinic Liver Cancer (BCLC)
categorization were as follows: 0 (6 %), A1 (59.5 %), A2
(6.9 %), A4 (2.9 %), and B (27.2 %). Four patients required
conversion to other techniques (2.3 %) because of the potential
for major bleeding and tumor perforation. The types of
resection were resection of one segment (segments 2, 3, 4, 5, 6,
7, and 8; 43.8 %), resection of two segments (posterior sector,
anterior sector, segments 5 and 6, and left lateral sector;
47.9 %), resection of three segments (left and central liver;
4.7 %), and four segments (right liver; 3.6 %). The mean
operation time was 112 ± 56 min (range 30–345 min), and
the median blood loss was 100 ml (range 20–1,200 ml). The
mean hospital stay was 6.5 ± 2.0 days (range, 3–19 days). No
perioperative mortality occurred. The overall survival rates
were 94.2 % at 1 year, 87 % at 2 years, 72.9 % at 3 years,
72.9 % at 4 years, and 72.9 % at 5 years. The mean overall
survival time was 49.7 ± 2.1 months (range 45.5–
53.9 months). The disease-free survival rates were 79.1 % at
1 year, 60 % at 2 years, 57 % at 3 years, 52 % at 4 years, and
26.3 % at 5 years. The mean disease-free survival time was
38.9 ± 2.6 months (range 33.9–44.0 months).
Conclusion Laparoscopic liver resection for HCC is
feasible, safe, and effective, with good oncologic results.
Major and anatomic hepatectomy are possible with
improved skill and experience. Laparoscopic liver resec-
tion is a promising treatment option with minimally inva-
sive benefits for HCC patients.
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potentially curative and popularized therapy for HCC.
However, due to the special anatomic position of the liver,
hepatectomy usually requires a very long incision, resulting
in postoperative pain and discomfort. Laparoscopic surgery
with minimally invasive techniques potentially brings
benefits to patients who need liver resection for HCC.
Although laparoscopic liver resections have been per-
formed for several years, the technique has not been widely
used as expected. This type of operation has the following
unsolved difficulties: surgical techniques that are not
standardized, dissection and control of the hepatic hilus
that still are challenging for laparoscopic surgeons, risk of
massive bleeding and difficulty with bleeding control
during liver parenchyma transection, establishment of on-
cologic principles in laparoscopic surgery for HCC, and
long-term oncologic follow-up evaluation of the technique.
Resolving the aforementioned issues requires a study
with a large number of patients and long-term follow-up
assessment to evaluate the role of laparoscopic liver
resection for HCC. This study aimed to evaluate the
effectiveness, safety, and benefits of laparoscopic liver
resection for HCC with long-term results.
Materials and methods
This cohort study with 5-year results of total laparoscopic
hepatectomy for HCC was conducted in one center. The
operation was performed by one team of surgeons. The fol-
low-up protocol was similar to that for open surgery. The
patients returned for follow-up evaluation every 2 months
after the operation. Patient data were collected and analyzed
using SPSS software (SPSS, Chicago, IL, USA).
Patient selection for laparoscopic liver resection
Tumors were free of major vessels, located in accessible
segments of the liver, and amenable to curative resection.
The tumors were smaller than 10 cm in the left liver and
smaller than 5 cm in the right liver. Liver function was
according to Barcelona Clinic Liver Cancer (BCLC) criteria
and did not exceed class B. Patients whose overall status was
categorized as American Society of Anesthesiology classes 1
to 3 were selected for laparoscopic liver resection.
Operative technique
We performed pure laparoscopic liver resection.
Patient position
For left lateral segmentectomy or anterior segmentectomy,
the patient was placed in supine position with open legs. A
posterior segmentectomy was performed with the patient in
left lateral recumbent position.
Trocar placement
We used five trocars and 45 oblique scopes. An infra-
umbilical trocar was used for the scope, and the camera
holder stood between the patient’s legs. The two right-
sided trocars were for the surgeon and the two left-sided
trocars for the assistant. The port positions were dependent
on the tumor location.
After mastering the learning curve, we improved and
standardized our surgical technique. Extra-Glissonean
dissection and anatomic liver resection were applied lap-
aroscopically. We controlled the correlative Glissonean
pedicle before transecting the liver parenchyma.
Left lateral sectorectomy
The left hepatic pedicle was temporarily controlled by a
vessel clamp (laparoscopic bulldog). The liver parenchyma
was transected with a Harmonic scalpel. The Glissonean
pedicles of segments 2 and 3 and the left hepatic vein were
divided by a vascular stapler or a Hemlock clip. Finally, the
vessel clamp at the left hepatic pedicle was released, and
hemostasis in the transection plane was performed with
bipolary cautery.
Left or right hepatectomy (Fig. 1)
After cholecystectomy, we continued with extra-Glisso-
nean dissection to expose the left or right pedicle. Then the
hemi-hepatic pedicle was controlled temporarily with a
vessel clamp (laparoscopic bulldog) to identify the dis-
coloration on the surface of the liver. It is mandatory to
ensure the anatomic border of the remnant liver and the
intactness of the major vessels.
The Glissonean pedicle was divided by the vascular
stapler. The liver parenchyma was transected with the
Harmonic scalpel from inferior to superior and from
anterior to posterior. Hemostasis on the liver plane was
performed using bipolar cautery. The left or right hepatic
vein was transected with the vascular stapler or controlled
with the Hemlock clip. The specimen was withdrawn
through the expanded infraumbilical trocar.
Anatomic sectorectomy or segmentectomy in the right
liver (Fig. 2)
We performed extra-Glissonean dissection to control the
inflow to the correlative segment (anterior or posterior
pedicle). The Glissonean pedicle was temporarily clamped
with a laparoscopic vessel clamp. The borders of the
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segment then were identified by discoloration on the sur-
face of the liver. The parenchyma was transected with the
Harmonic scalpel. Bleeding points were controlled with
bipolar cautery.
Results
From January 2008 to December 2012, 173 patients with
HCC were enrolled for totally laparoscopic liver resections.
The male-to-female ratio was 3:1, and the mean of age of
the patients was 56 years (range 16–83 years).
For all the patients, HCC was diagnosed according to
the American Association for the Study of Liver Diseases
(AASLD) criteria. The number of operations increased
annually, including laparoscopic major liver resection. The
numbers of patients undergoing totally laparoscopic liver
resection from 2008 to 2012 were 21 in 2008, 36 in 2009,
39 in 2010, 31 in 2011, and 46 in 2012.
Totally laparoscopic liver resections for HCC were
performed for 169 patients (97.7 %). The conversion rate
was 2.3 %. Two patients underwent conversion to an open
procedure due to high risk of major bleeding, and two
patients underwent conversion due to high risk of tumor
perforation. Two of these four patients had tumors located
on segment 5 that caused major bleeding from the right
portal vein. The remaining two patients also had tumors
located on segment 5 that were encountered during the
parenchymal transaction, which was converted to ensure a
sufficient oncologic margin.
The mean tumor size was 3.73 cm (range 2–10 cm).
According to the BCLC staging system, 3.5 % of our
patients had very-early-stage disease (0), 69.3 % had early-
stage disease (A), and 27.2 % had intermediate-stage dis-
ease (B) involving a single tumor larger than 5 cm in
diameter (Table 1).
Table 2 shows the types of resection performed for our
patients. The mean operation time was 112 ± 56 min
(range 30–345 min). The median blood loss was 100 ml
(range 20–1,200 ml), and the mean hospital stay was
6.5 ± 2.0 days (range 3–19 days) (Table 3).
During the follow-up period of 21.6 ± 16.0 months
(range 0–60 months), we lost 39 patients. The disease-free
survival rates in this study were 79.1 % at 1 year, 60 % at
Table 1 Clinicopathologic patient data
Variables Frequency Range/
percentage
Mean age (years) 56.54 16–83
Sex (male/female)
Mean tumor size (cm) 3.73 2–10







Mean operation time (min) 112 ± 56 30–345
Median blood loss (ml) 100 20–1,200
Surgical margin
Close 10 5.9
\1 cm 13 7.7
1–2 cm 89 52.7





Positive margin/negative margin 4/165 2.4/97.6
Hospital stay (days) 6.5 ± 2.0 3–19
Complications
Ascites after surgery 1 0.6
Pneumonia 1 0.6
Bile leakage 2 1.2
Peri-operation mortality 0 0
Mean follow-up time (months) 21.6 ± 16.0 0–60
Follow-up lost patients 130 39
Mean disease-free survival (months) 38.9 ± 2.6 33.9–44.0
Table 2 Type of resection
Type of resection n %
One segment
Segment 2 8 4.7
Segment 3 6 3.6
Segment 4 10 5.9
Segment 5 14 8.3
Segment 6 27 16.0
Segment 7 7 4.1
Segment 8 2 1.2
Two segments
Posterior sector 7 4.1
Anterior sector 2 1.2
Segments 5 & 6 14 8.3
Left lateral sector 58 34.3
Three segments
Left liver 7 4.1
Central segments of liver 1 0.6
Four segments
Right liver 6 3.6
Total 169 100
798 Surg Endosc (2014) 28:796–802
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2 years, 57 % at 3 years, 52 % at 4 years, and 26.3 % at
5 years (Fig. 1). The mean disease-free survival time was
38.9 ± 2.6 months (range 33.9–44.0 months). The overall
survival rates were 94.2 % at 1 year, 87 % at 2 years,
72.9 % at 3 years, 72.9 % at 4 years, and 72.9 % at 5 years
(Fig. 2). The mean overall survival time was
49.7 ± 2.1 months (range 45.5–53.9 months) (Figs. 3, 4).
Discussion
In our center, we initiated our laparoscopic liver resection
experience in 2005. The surgical techniques have been
standardized and applied consistently since 2008. In this
study, 173 consecutive patients with HCC who underwent
totally laparoscopic liver resection were followed up for
evaluation of the long-term results.
Indication and feasibility of laparoscopic liver resection
Hepatocellular carcinoma was diagnosed according to the
criteria of AASLD [1]. At the beginning, laparoscopic liver
Fig. 1 Laparoscopic right Glissonean pedicle transection after dissection
Fig. 2 Laparoscopic Glissonean pedicle dissection
Table 3 Surgical factors
Variables Frequency % Range
Mean operation time (min) 112 ± 56 30–345
Median blood loss (ml) 100 20–1,200
Surgical margin
Close 10 5.9
\1 cm 13 7.7
1–2 cm 89 52.7





Positive margin/negative margin 4/165 2.4/97.6
Hospital stay (days) 6.5 ± 2.0 3–19
Complications
Ascites after surgery 1 0.6
Pneumonia 1 0.6
Bile leakage 2 1.2
Perioperation mortality 0 0
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resection was indicated for peripheral tumor, especially for
tumor located on the left lobe of the liver. For tumor in
segment 2, 3, or 6, it is easier to apply the laparoscopic
technique because liver mobilization is not required, the
plane of transection is straightforward, and bleeding is
controlled more easily. Laparoscopic liver resection helped
patients to avoid the long incision needed in open surgery.
For tumor in the left lateral sector, we used the vascular
stapler to divide the Glissonean pedicle and the left hepatic
vein. This technique is feasible and safe, with short oper-
ative times. The current study showed that left lateral
sector resection accounts for the largest percentage
(34.5 %) of the operation. The World Consensus Confer-
ence on Laparoscopic Surgery for Liver Resection 2008
accepted laparoscopic left lateral sector resection as the
standard operation for HCC [2].
Despite their peripheral position, tumors in segment 4b
or 5 are in close proximity to adjacent major structures of
the hepatic pedicle. In addition, the transection plan zig-
zags and is not a straight line and thus is more difficult.
In this study, we had seven tumors on segment 7
(4.1 %). We performed laparoscopic atypical liver resec-
tion successfully in all these patients. However, we rec-
ognize that this is quite difficult because it requires
complete mobilization of the right liver and because the
nonanatomic segment 7 resection is harder to perform.
For most of the patients, we were successful in com-
pleting a totally laparoscopic resection. Only in four
patients (2.3 %) was this technique not possible for tumors
located in segment 5. Two of these four patients underwent
conversion due to difficulty controlling bleeding, and the
remaining two underwent conversion because the surgical
margin was too close to the portal vein. No emergency
conversion to an open surgical technique was performed.
Temporary clips or suture for hemostasis before a change
to another technique was safe and suitable. Other tech-
niques such as hand-assisted or hydrid technique were
beneficial to the patients.
Based on our results, laparoscopic liver resection of
HCC located on peripheral segments (segments 2, 3, 4a, 5,
and 6) and not too close to major structures is safe and
feasible, consistent with the literature [2–6].
Recently, we applied the intrahepatic Glissonean
approach for dissection of the Glissonean pedicles to each
segment separately before transecting the parenchyma. The
approach was similar to the approach described by Mach-
ado et al. [3] and Cho et al. [4]. We considered this tech-
nique to be useful in laparoscopic surgery for help in
identifying the anatomic borders of the segment with intent
for resection, for selective control of the hepatic inflow, for
reduction of ischemia to the remnant liver, for facilitation
of the anatomic resection, and for help in ensuring the
oncologic margin.
Several reports have shown the feasibility of major liver
resections [5–10] and anterosuperior sectorectomy [11–13].
Most authors agree that laparoscopic surgery for major liver
resection has complications similar to those of open surgery
but offers the benefits of laparoscopic surgery [14] .
After increasing our experience with more straightfor-
ward laparoscopic liver resections, we broadened our
indication for laparoscopic liver resections to major liver
resection and anatomic liver resection. Our study had six
patients (3.6 %) with right liver resection, seven patients
(4.1 %) with left liver resection, seven patients (4.1 %)
with posterior sectorectomy, two patients (1.2 %) with
anterior sectorectomy, and one patient (0.6 %) with central
hepatectomy.
Fig. 3 Disease-free survival curve (Kaplan–Meier)
Fig. 4 Overall survival curve (Kaplan–Meier)
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The mean tumor size in our study was 3.73 cm (range
2–10 cm). Tumor size was not a critical factor in choosing
between laparoscopic and open liver resection. However,
we agree that large tumors impeded the operative tech-
niques and increased the risk of tumor perforation. Tumor
location and relation to other structures are more important
in the choice of the operation.
Most cases of HCC have developed in a background of
cirrhosis or chronic hepatitis. In our study, most of the
patients had cirrhosis. However, several authors have rec-
ognized that laparoscopic liver resection has more benefits
for patients with cirrhosis. Especially, postoperative ascites
were less frequent because of the minimal invasion to
lateral circulation [15] .
Parenchymal transection and blood loss control
After selective control of the hepatic inflow, we transected
the parenchyma with the Harmonic scalpel. Hemostasis was
secured with bipolar cautery, and large vessels were clipped
with Hemolock clips and divided. Application of this tech-
nique was effective, leading to short operative times and
reducing the ischemia to the remnant liver. Our mean oper-
ative time was 112 ± 56 min (range 30–345 min).
Some authors have used the laparoscopic cavitron
ultrasonic surgical aspirator (CUSA), a meticulous hemo-
static instrument that helps to reduce bleeding but prolongs
the operative time. In our study, the median blood loss was
194 ml (range 20–1200 ml). Selective control of the
hepatic inflow with the intrahepatic Glissonean approach
followed by parenchymal transection with the Harmonic
scalpel according to the anatomic border reduces blood loss
and facilitate laparoscopic surgery.
Specimen pathologic result and surgical margin
Our goal for the surgical margin was a distance of at least
1 cm from the tumor. Based on the location of the tumor
identified on imaging studies, we planned the appropriate
liver resection with a margin greater than 1 cm in mind,
ensuring adequate remnant liver volume. The surgical
margins for 5.9 % of the tumors were too close to the
tumor, and 7.7 % of the tumors had a margin of less than
1 cm. In these instances, the tumor was located too close to
major vessels.
As Han et al. [16] reported, when intraoperative ultra-
sound is used to identify the tumor location and confirm the
expected margin, sometimes this margin cannot be
obtained with laparoscopic surgery. In laparoscopic sur-
gery, tactile feedback is not possible for identification of
the deep tumor and the tumor located too close to major
vessels. Others have reported that 13 % of surgical margins
are less than 1 cm from the tumor [17, 18]. These authors
have concluded that this rate is similar to that in open
surgery.
Hospital stay
The hospital stay in our study was 6.5 ± 2.0 days (range
3–19 days). In other studies [19, 20], hospital stay in lap-
aroscopic group was shorter than in the open group. For
peripheral tumors, such as tumor in left lateral segments or
segment 6, the hospital stays were 3 days. Moreover, the
patients felt less pain postoperatively and returned to nor-
mal activities more quickly.
Complications
No perioperative mortality occurred in our study. Com-
plications occurred such as burden postoperative ascites
(0.6 %), bile leak (1.2 %), and pneumonia (0.6 %). Ngu-
yen et al. [9] reviewed 127 published papers on laparo-
scopic liver resection and found a cumulative mortality rate
of 0.3 % and a morbidity rate of 10.5 %. The liver-specific
complications included bile leaks (1.5 %), transient liver
ascites (1 %), and abscesses (2 %). Our study had two
cases with major bleeding intraoperatively that required a
conversion of operative technique but no emergency con-
version. Several reports described complications of lapa-
roscopic liver resection, with most of them suggesting that
open and laparoscopic surgeries do not differ significantly
in terms of complications [21].
Survival and recurrence
The recurrence and survival rates were the most important
factors in the treatment of HCC with laparoscopic liver
resection. Our follow-up protocol included reexamination of
all patients every 2 months. Throughout the study, 130
patients were followed up. During the study period, 39
patients died. We had no peritoneal or port-site recurrence in
the current study. The disease-free survival rates were 79.1 %
at 1 year, 57 % at 3 years, and 26.3 % at 5 years. In most
cases, recurrent HCC tumors were diagnosed early and treated
by reoperation, Radio Frequency Ablation, or Transcatheter
arterial chemoembolization to prolong survival.
The overall survival rates in this study were 94.2 % at
1 year, 72.9 % at 3 years, and 72.9 % at 5 years. From a
European perspective, Kluger and Cherqui [22] reported
the overall survival rates after liver resection for 163
patients with HCC to be 92.6 % at 1 year, 68.7 % at
3 years, and 64.9 % at 5 years and the disease-free survival
rates to be 77.5 % at 1 year, 47.1 % at 3 years, and 32.2 %
at 5 years.
In 2009, Nguyen et al. [9] in their review of laparoscopic
liver resections reported 5-year overall survival rates after
Surg Endosc (2014) 28:796–802 801
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laparoscopic liver resection ranging from 50 to 70 % and
disease-free survival rates ranging from 31 to 38.2 %.
These results were comparable with those for open surgery.
Sarpel et al. [20] and Ito et al. [19] conducted a retro-
spective case-matched study including comparable factors
such as degree of cirrhosis and tumor characteristics. They
suggested that no significant difference in outcome existed
between the two groups.
Conclusion
Laparoscopic liver resection for HCC is feasible, safe, and
effective, with good oncologic results. Major and anatomic
hepatectomy can be performed more common by improv-
ing skill and experience. Laparoscopic liver resection is a
promising treatment option with mini-invasive benefits for
HCC patients.
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